Literature DB >> 30191962

Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?

Faroogh Marofi1, Ghasem Vahedi2, Ali Hasanzadeh1, Sadegh Salarinasab3, Pishva Arzhanga4, Bahareh Khademi5, Majid Farshdousti Hagh6.   

Abstract

Recently a growing attention in scientific community has been gathered on potential application of mesenchymal stem cells (MSCs) in various fields of medicine. Owing to the fact that they can be easily isolated from different sources, and simply proliferated in large quantities while keeping their original biological characteristics, they can be successfully used as cell-based therapeutics. Engineering MSCs and other type of stem cells to be carriers of therapeutic agents is a new tactic in the targeted gene and cell therapy of cancers and degenerative diseases. Various useful properties of MSCs including tropism toward tumor/injury site(s), weakly immunogenic, production of anti-inflammatory molecules, and safety against normal tissues have made them prone for regenerative medicine, targeted therapy and treating injured tissues, and immunological abnormalities. In this review, we introduce latest advances, methods, and applications of MSCs in gene therapy of various malignant organ disorders. Additionally, we will cover the problems and challenges which researchers have faced with when trying to translate their basic experimental findings in MSCs research to clinically applicable therapeutics.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cell therapy; gene delivery; gene therapy; mesenchymal stem cells; regenerative medicine; target therapy

Year:  2018        PMID: 30191962     DOI: 10.1002/jcp.27152

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.

Authors:  Xiaoyu Yang; Yan Wang; Heshu Sulaiman Rahman; Talar Ahmad Merza Mohammad; Amin Daei Sorkhabi; Stanislav Evgenievich Korsakov; Lakshmi Thangavelu; Ali Adili; Aila Sarkesh; Rozita Tamjidifar; Hossein Saeedi; Ramin Aslaminabad; Saeed Tarzi; Morteza Akbari
Journal:  Med Oncol       Date:  2022-05-18       Impact factor: 3.064

Review 2.  Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis.

Authors:  Xiufen Zhuang; Xiao Hu; Shuren Zhang; Xingmin Li; Xiaoying Yuan; Yanhong Wu
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

3.  Optimizing human endometrial mesenchymal stem cells for maximal induction of angiogenesis.

Authors:  Jie Zhang; Huifang Song; Xuemei Fan; Sheng He; Wenjuan Yin; Zexu Peng; Xiaoyan Zhai; Kun Yang; Hui Gong; Zhijun Wang; Yi Ping; Sanyuan Zhang; Ren-Ke Li; Jun Xie
Journal:  Mol Cell Biochem       Date:  2022-10-20       Impact factor: 3.842

4.  Human Bone Marrow Mesenchymal Stromal Cells Attenuate Tissue Injury and Reduce Inflammation in Experimental Acute Pancreatitis.

Authors:  Tayebeh Mahmoudi; Ali Jalili; Kamal Abdolmohammadi; Shohreh Fakhari; Fatemeh Pahlavan; Ali Shekari; Bahram Nikkhoo; Lobat Tayebi; Mohammad Reza Rahmani
Journal:  Adv Pharm Bull       Date:  2021-01-31

5.  Chemical activation of the Piezo1 channel drives mesenchymal stem cell migration via inducing ATP release and activation of P2 receptor purinergic signaling.

Authors:  Fatema Mousawi; Hongsen Peng; Jing Li; Sreenivasan Ponnambalam; Sébastien Roger; Hucheng Zhao; Xuebin Yang; Lin-Hua Jiang
Journal:  Stem Cells       Date:  2020-01-21       Impact factor: 6.277

Review 6.  Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.

Authors:  Alexander Markov; Lakshmi Thangavelu; Surendar Aravindhan; Angelina Olegovna Zekiy; Mostafa Jarahian; Max Stanley Chartrand; Yashwant Pathak; Faroogh Marofi; Somayeh Shamlou; Ali Hassanzadeh
Journal:  Stem Cell Res Ther       Date:  2021-03-18       Impact factor: 6.832

7.  Fibronectin within Sodium Alginate Microcapsules Improved Osteogenic Differentiation of BMMSCs in Dose Dependent Manner by Targeting SP7, OCN, CDK1, ZBTB16, and Twist1 Expression.

Authors:  Karim Shamsasenjan; Younes Beygi Khosrowshahi; Mahsa Mahmoodi; Parvin Akbarzadehlaleh; Nesrin Gareayaghi; Babak Nejati
Journal:  Adv Pharm Bull       Date:  2021-08-07

Review 8.  Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review.

Authors:  Samin Shokravi; Vitaliy Borisov; Burhan Abdullah Zaman; Firoozeh Niazvand; Raheleh Hazrati; Meysam Mohammadi Khah; Lakshmi Thangavelu; Sima Marzban; Armin Sohrabi; Amir Zamani
Journal:  Stem Cell Res Ther       Date:  2022-05-08       Impact factor: 8.079

Review 9.  A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.

Authors:  Soudeh Moghadasi; Marischa Elveny; Heshu Sulaiman Rahman; Wanich Suksatan; Abduladheem Turki Jalil; Walid Kamal Abdelbasset; Alexei Valerievich Yumashev; Siavash Shariatzadeh; Roza Motavalli; Farahnaz Behzad; Faroogh Marofi; Ali Hassanzadeh; Yashwant Pathak; Mostafa Jarahian
Journal:  J Transl Med       Date:  2021-07-12       Impact factor: 5.531

Review 10.  Stem-cell therapy for hearing loss: are we there yet?

Authors:  Luiz Gustavo Dufner-Almeida; Dayane Bernardino da Cruz; Regina Célia Mingroni Netto; Ana Carla Batissoco; Jeanne Oiticica; Rodrigo Salazar-Silva
Journal:  Braz J Otorhinolaryngol       Date:  2019-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.